Results 91 to 100 of about 1,181 (167)

[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps]. [PDF]

open access: yesHNO, 2021
Klimek L   +6 more
europepmc   +1 more source

Advancing early access policies for innovative cancer drugs: a scoping review and explorative analysis in the Italian setting. [PDF]

open access: yesJ Pharm Policy Pract
d'Errico M   +5 more
europepmc   +1 more source

Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose. [PDF]

open access: yesEur J Health Econ
Schweitzer MK   +11 more
europepmc   +1 more source

Indication-wide drug pricing: Insights from the pharma market. [PDF]

open access: yesJ Pharm Policy Pract, 2022
Siegmeier F, Büssgen M.
europepmc   +1 more source

Pricing combination products: not how but who? [PDF]

open access: yesEur J Health Econ
Towse A, Briggs A, Steuten L.
europepmc   +1 more source

Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs. [PDF]

open access: yesJ Patient Rep Outcomes, 2021
Haag S   +6 more
europepmc   +1 more source

Topics in health economics and social policy : Abstracts of the 7th DIBOGS-Workshop, Düsseldorf 2012 [PDF]

open access: yes, 2013
Banduhn, Carolin   +8 more
core  

Home - About - Disclaimer - Privacy